Related Experiment Video
Updated: Jul 2, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Optical contrast agents and imaging systems for detection and diagnosis of cancer
Mark C Pierce1, David J Javier, Rebecca Richards-Kortum
1Department of Bioengineering, Rice University, Houston, TX, USA.
Abstract:
Molecular imaging has rapidly emerged as a discipline with the potential to impact fundamental biomedical research and clinical practice. Within this field, optical imaging offers several unique capabilities, based on the ability of cells and tissues to effect quantifiable changes in the properties of visible and near-infrared light. Beyond endogenous optical properties, the development of molecularly targeted contrast agents enables disease-specific morphologic and biochemical processes to be labeled with unique optical signatures. Optical imaging systems can then provide real-time visualization of pathophysiology at spatial scales from the subcellular to whole organ levels. In this article, we review fundamental techniques and recent developments in optical molecular imaging, emphasizing laboratory and clinical systems that aim to visualize the microscopic and macroscopic hallmarks of cancer.
Insights
Optical imaging advances biomedical research and clinical practice by visualizing cellular and tissue changes. This technique uses light interactions and targeted agents for real-time disease visualization, particularly in cancer research.
Area of Science:
- Biomedical optics
- Molecular imaging technologies
Background:
- Molecular imaging is a rapidly growing field with significant potential in biomedical research and clinical applications.
- Optical imaging leverages the interaction of light with biological tissues for diagnostic and research purposes.
Purpose of the Study:
- To review fundamental techniques and recent developments in optical molecular imaging.
- To highlight laboratory and clinical systems for visualizing cancer hallmarks.
Main Methods:
- Utilizing endogenous optical properties of cells and tissues.
- Employing molecularly targeted contrast agents for specific labeling.
- Developing optical imaging systems for real-time visualization.
Main Results:
- Optical imaging enables quantifiable changes in light properties within cells and tissues.
- Targeted agents provide unique optical signatures for disease processes.
- Systems visualize pathophysiology from subcellular to whole organ levels.
Conclusions:
- Optical molecular imaging offers unique capabilities for biomedical research and clinical practice.
- The technology facilitates real-time visualization of disease, especially cancer.
- Continued advancements promise broader applications in diagnostics and therapy.
More Related Videos
09:37Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
12:24Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012
Related Concept Videos
X-ray Imaging
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies III: Computed Tomography